Meta-Analysis of Results From Eight Randomized, Placebo-Controlled Trials of the Effect of Cilostazol on Patients With Intermittent Claudication - Meta-Analysis of Results From Eight Randomized, Placebo-Controlled Trials of the Effect of Cilostazol on Patients With Intermittent Claudication

Description:

The goal of this study was to assess the safety and efficacy of cilostazol or Pletal, a type III phosphodiesterase inhibitor, arterial vasodilator, and platelet antagonist among patients limited by leg claudication.